Home » Analyst: Riata Ruckus Won’t Hurt CRM Market Long-Term
Analyst: Riata Ruckus Won’t Hurt CRM Market Long-Term
The high-profile furor over St. Jude Medical’s recalled Riata defibrillator leads last week won’t have a lasting impact on the overall cardiac rhythm management market, said Barclays Capital analyst Adam Feinstein.
Mass Device
Mass Device
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May